Arcus Biosciences, Inc.
A clinical-stage biopharma developing small molecule and antibody combination therapies for cancer.
RCUS | NYSE
Overview
Corporate Details
- ISIN(s):
- US03969F1093
- LEI:
- Country:
- United States of America
- Address:
- 3928 POINT EDEN WAY, 94545 HAYWARD
- Website:
- https://arcusbio.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Arcus Biosciences, Inc. is a clinical-stage, global biopharmaceutical company focused on developing and commercializing innovative therapies for people with cancer. Founded in 2015, the company specializes in creating differentiated small molecules and antibodies, with a strategic emphasis on developing best-in-class combination medicines, particularly in the field of immuno-oncology. Arcus integrates its discovery capabilities with an accelerated development process to advance novel treatments from early-stage clinical studies through potential commercialization. The company actively partners with the global cancer community to facilitate clinical trials and expedite the delivery of new treatments to patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Arcus Biosciences, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Arcus Biosciences, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Arcus Biosciences, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
